Structural heart disease

There are 34 papers on structural heart disease in aging research: 1 trial and 20 observational studies in people, 10 reviews. The newest story, Nov 9, 2026: “Artificial intelligence better flags structural heart disease”.

Disease

34 papers study it45 more mention it7 findings

21 new papers in 30 daysSee all 79 papers on structural heart disease

“In contrast, AI-ECG had substantially higher performance (AUROC 0.73; PPV 0.29, NPV 0.93 at Youden’s J threshold).”
AI-enabled ECG for Structural Heart Disease Diagnosis Improves Triage of Echocardiography Referral in a Low-Resource Setting: The PROVAR+ StudyAHA Scientific Sessions 2025 abstract2025doi:10.1161/circ.152.suppl_3.4369244
  • Human trial1
  • Humans20
  • In silico2

Associations

7

AI-ECG-SHD probability

upin humans1OR 1.55

1 study
  1. AI-ECG-SHD probability is associated with structural heart disease in humans (Adults undergoing public-system cardiovascular screening) (OR 1.55 per 10% increase, 95% CI 1.51–1.61).

    HumansAdults undergoing public-system cardiovascular screening56.7% womensn = 3,779

    Artificial intelligence better flags structural heart disease

    The American journal of cardiology

More on AI-ECG-SHD probability

Echonext

downin humans1

1 study
  1. Echonext predicts structural heart disease in humans (community-dwelling population) (AUC 71% vs 83%).

    Humanscommunity-dwelling populationn = 2,402

    Heart disease AI performed less well in a community study

    Journal of the American College of Cardiology

More on Echonext

ADAPT-HEART probability of SHD

upin humans1

1 study
  1. ADAPT-HEART probability of SHD predicts structural heart disease in humans (AUROC 0.913 (95% CI, 0.837–0.989)).

    Human trialn = 597

More on ADAPT-HEART probability of SHD

Traditional ecg interpretation

no changein humans1

1 study
  1. Traditional ecg interpretation predicts structural heart disease in humans (screening for probable structural heart disease) (AUROC 0.52, PPV 0.18, NPV 0.86).

    Human trialscreening for probable structural heart diseaseheartn = 3,282

More on Traditional ecg interpretation

Ai-ecg

upin humans1

1 study
  1. Ai-ecg predicts structural heart disease in humans (screening for probable structural heart disease) (AUROC 0.73, PPV 0.29, NPV 0.93).

    Human trialscreening for probable structural heart diseaseheartn = 3,282

More on Ai-ecg

Poor olfaction

upin humans1

1 study
  1. Poor olfaction is associated with structural heart disease in humans.

    Humansn = 5,217

Diastolic electromechanical asynchrony

upin humans1

1 study
  1. Structural heart disease is associated with diastolic electromechanical asynchrony in comparison to the healthy subgroup.

    Humansin comparison to the healthy subgroup

Trial sponsors

Funding

2 grants since 2023

American Heart Association$3.5MNational Heart, Lung, and Blood Institute$662K

Latest

Dec 2025: 1Jan 2026: 3Feb 2026: 5Mar 2026: 5Apr 2026: 1May 2026: 2Jun 2026: 1Jul 2026: 5Aug 2026: 3Sep 2026: 5Oct 2026: 7Nov 2026: 1452 papers in 12 months
The American Journal of Cardiology

Artificial intelligence better flags structural heart disease

The model’s score for distinguishing disease from no disease was 0.80, versus 0.75 for prediction using clinical information and standard heart-tracing findings.The model’s score for distinguishing disease from no disease was 0.80, versus 0.75 for prediction using clinical information and standard heart-tracing findings.

Cross-sectional · 3,779 peopleStructural heart disease
AHA Scientific Sessions 2026 Abstract

AI heart-tracing screens linked to later heart failure

Positive combined screens were linked to 3.4-fold and 4.3-fold relative heart failure risks versus negative screens at Massachusetts General and Emory, respectively.Positive combined screens were linked to 3.4-fold and 4.3-fold relative heart failure risks versus negative screens at Massachusetts General and Emory, respectively.

Cohort studyHeart failure

See all 79 papers on structural heart disease